期刊文献+

多聚腺苷二磷酸核糖聚合酶及其抑制剂在创伤性脑损伤治疗方面的研究进展 被引量:2

下载PDF
导出
摘要 多聚腺苷二磷酸核糖聚合酶(poly ADP-ribose polymerase,PARP)在DNA损伤修复、维持基因组稳定性方面起着重要作用。笔者对PARP的结构和生物学功能进行简要介绍,归纳近几年PARP抑制剂在创伤性脑损伤方面的研究成果,并提出临床策略中可能存在的问题以及未来发展方向。
出处 《中国医刊》 CAS 2015年第3期13-16,共4页 Chinese Journal of Medicine
基金 国家自然科学基金(81171144 81471238)
  • 相关文献

参考文献29

  • 1Lucio T, Ilaria P, Grazia G. Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors [ J ]. Pharmacol Res, 2002,45(2) :73-85.
  • 2Abd Elmageed ZY, Naura AS, Errami Y, et al. The poly ( ADP-ri- bose) polymerases (PARPs):new roles in intracellular transport [ J]. Cell Signal,2012,24( 1 ) :1-8.
  • 3Luo X, Kraus WL. On PAR with PARP: cellular stress signaling through poly (ADP-ribose) and PARP-1 [ J ]. Genes Dev, 2012,26 (5) :417-432.
  • 4Herceg Z, Wang ZQ. Functions of Poly ( ADP-ribose ) Polymerase (PARP) in DNA repair,genomic integrity and cell death[J]. Mutat Res,2001,477(1-2) :97-110.
  • 5Ame JC, Spenlehauer C, de Murcia G. The PARP supeffamily [ J]. Bio Essays,2004,26 ( 8 ) : 882-893.
  • 6Sodhi RK, Singh N, Jaggi AS. Poly ( ADP-ribose ) polymerase-1 (PARP-I) and its therapeutic implications [ J ]. Vascul Pharmacol, 2010,53(3-4) :77-87.
  • 7Welsby I, Hutin D, Leo O. Complex roles of members of the ADP-ri- bosyl transferase superfamily in immune defences: looking beyond PARP1 [ Jl. Biochem Pharmaco1,2012,84( 1 ) :11-20.
  • 8Kun E, Bauer PI. Cell biological functions of PARP I : an overview [ J]. Ital J Biochem,2001,50(1-2) :15-18.
  • 9Yung TM, Sato S, Satoh MS. Paly (ADP-ribosy!) ation as a DNA damage-induced post translational modification regulating poly (ADP-ribose) polymerase-1- topoisomerase I interaction [ J]. J Bi- ol Chem ,2004,279 ( 38 ) :39686-39696.
  • 10王慧源,孙宏斌.聚腺苷二磷酸核糖聚合酶的功能及其抑制剂潜在的临床应用[J].中国临床药理学与治疗学,2007,12(7):743-747. 被引量:2

二级参考文献28

  • 1Tentori L,Portarena I,Graziani G.Potential clinical applications of poly(ADP-ribose) polymerase inhibitors[J].Pharmacol Res,2002;45:73-85.
  • 2Jagtap P,Szabo C.Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors[J].Nat Rev Drug Discov,2005;4:421-440.
  • 3Hanai S,Uchida M,Kobayashi S,et al.Genomic organization of Drosophila poly(ADP-ribose) polymerase and distribution of its mRNA during development[J].J Boil Chem,1998;273:11881-11886.
  • 4Nguewa PA,Fuertes MA,Valladares B,et al.Poly(ADP-ribose) polymerases:homology,structural domains and functions.Novel therapeutical applications[J].Prog Biophys Mol Biol,2005;88:143-172.
  • 5Davidovic L,Vodenicharov M,Affar EB,et al.Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism[J].Exp Cell Res,2001;268:7-13.
  • 6Kun E,Bauer PI.Cell biological functions of PARP I:an overview[J].Ital J Biochem,2001;50:15-18.
  • 7Yung TM,Sato S,Satoh MS.Poly(ADP-ribosyl)ation as a DNA damage-induced post-translational modification regulating poly(ADP-ribose) polymerase-1-topoisomerase I interaction[J].J Biol Chem,2004;279:39686-39696.
  • 8Flohr C,Burkle A,Radicella JP,et al.Poly(ADP-ribosyl)ation accelerates DNA repair in a pathway dependent on Cockayne syndrome B protein[J].Nucleic Acids Res,2003;31:5332-5337.
  • 9von Kobbe C,Harrigan JA,Schreiber V,et al.Poly(ADP-ribose) polymerase 1 regulates both the exonuclease and helicase activities of the Werner syndrome protein[J].Nucleic Acids Res,2004;32:4003-4014.
  • 10Virag L,Szabo C.The therapeutic potential of poly(ADP-ribose) polymerase inhibitors[J].Pharmacol Rev,2002;54:375-429.

共引文献1

同被引文献9

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部